Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
QuintilesIMS
Chubb
Merck
Covington
Daiichi Sankyo
Chinese Patent Office
Novartis
Healthtrust
Fuji

Generated: August 16, 2017

DrugPatentWatch Database Preview

Sermorelin acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sermorelin acetate and what is the scope of sermorelin acetate freedom to operate?

Sermorelin acetate
is the generic ingredient in one branded drug marketed by Emd Serono Inc and Emd Serono, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for sermorelin acetate.

Summary for Generic Name: sermorelin acetate

Tradenames:1
Patents:0
Applicants:2
NDAs:2
Drug Master File Entries: see list1
Bulk Api Vendors: see list11
Clinical Trials: see list915
Patent Applications: see list467
Drug Prices:see low prices
DailyMed Link:sermorelin acetate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emd Serono Inc
GEREF
sermorelin acetate
INJECTABLE;INJECTION020443-002Sep 26, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe
Emd Serono
GEREF
sermorelin acetate
INJECTABLE;INJECTION019863-001Dec 28, 1990DISCNYesNo► Subscribe► Subscribe► Subscribe
Emd Serono Inc
GEREF
sermorelin acetate
INJECTABLE;INJECTION020443-001Sep 26, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: sermorelin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Emd Serono
GEREF
sermorelin acetate
INJECTABLE;INJECTION019863-001Dec 28, 1990► Subscribe► Subscribe
Emd Serono Inc
GEREF
sermorelin acetate
INJECTABLE;INJECTION020443-001Sep 26, 1997► Subscribe► Subscribe
Emd Serono Inc
GEREF
sermorelin acetate
INJECTABLE;INJECTION020443-002Sep 26, 1997► Subscribe► Subscribe
Emd Serono Inc
GEREF
sermorelin acetate
INJECTABLE;INJECTION020443-001Sep 26, 1997► Subscribe► Subscribe
Emd Serono Inc
GEREF
sermorelin acetate
INJECTABLE;INJECTION020443-002Sep 26, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Harvard Business School
McKinsey
Medtronic
Fish and Richardson
Queensland Health
QuintilesIMS
Colorcon
Teva
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot